MARIPOSA: Combination therapy as the new standard of care for EGFR-mutated NSCLC - Medizinonline

… Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitreten Already a member? Log in here...

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten

Already a member? Log in here

Autoren

Birke Dikken

Publikation

InFo ONKOLOGIE & HÄMATOLOGIE

Related Topics

Previous Article

Atopic dermatitis and allergies Atopic dermatitis and allergies

Type 2 inflammation and other factors

Diabetes mellitus

Treatment of comorbidities in older people

You May Also Like

5 min

Psoriasis in the Age of Precision Medicine

Systemic Therapy for Patients with Comorbidities: What Is the Best Choice?

13 min

The AMALFI study and the limits of digital screening for atrial fibrillation

Remote monitoring for atrial fibrillation: lots of detection, little stroke prevention?

- RX
- Cardiology
- Education
- Studies

4 min

MASH

Pharmacotherapies as “Game Changers”—What Are the Upcoming Challenges?

13 min

Obesity Treatment

Oral GLP-1 Therapies: ATTAIN-1 and OASIS-4—The Next Leap Forward

5 min

Older patients with atopic dermatitis

Why the Use of Biologics Is Recommended

4 min

Disorders of the Gut-Brain Interaction

Peppermint-Caraway Oil Supplement Proves Effective in Phase IV Trial

5 min

Gepante for Migraines

Relief from pain, symptoms, and improved functional ability—both acute and preventive

12 min

Why the Finerenon Boom Is Giving Hyperkalemia Treatment New Relevance

Potassium binders as enablers of RAASi optimization

Input your search keywords and press Enter.